Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
Relish the World: Notable Caf\u00e9s You Really want to Attempt- Manual for Instructive Application for Youngsters
- IndiGo lands IATA chief Willie Walsh as new CEO
- The most effective method to Decisively Use Open Record Rewards
- Ukrainian man arrested in Germany on suspicion of spying for Russia
- Israeli lawmakers pass bill reviving death penalty for terrorists
- Administrative building in Sharjah region targeted by Iranian drone, UAE authorities announce
- ‘RichTok’ Influencer Becca Bloom Shows Off Custom Invitations and ‘Most Valued Possession’ from Her Viral 2025 Wedding
- A Manual for Pick Viable Psychological well-being Backing Administrations In 2024
